Posted on Tuesday, August 4th, 2020 by MarketBeat StaffEvery trading day, between 500 and 800 new recommendations and research reports are issued by sell-side equities research analysts. There are between 300 and 500 brokerages and research houses that issue ratings, price targets and recommendations and more than 5,000 securities around the world that regularly receive coverage from research analysts.
MarketBeat has tracked more than 170,000 distinct analyst recommendations in the last 12 months alone. Given the volume of ratings changes that occur each day, it can be difficult to sift through the noise.
Analysts don't always get their "buy" ratings right, but it's worth taking a hard look when more than a dozen different analysts from different brokerages and research firm are giving "strong buy" and "buy" ratings to the same stock.
This slide show lists the 20 companies that have the highest average analyst recommendations from Wall Street's equities research analysts over the last 12 months.
#1 - LHC Group (
NASDAQ:LHCG)
Consensus Rating: Buy
Rating Score: 2.8
Ratings Breakdown: 8 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $165.67 (-16.1% Upside)
LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.
Read More #2 - Synopsys (
NASDAQ:SNPS)
Consensus Rating: Buy
Rating Score: 3.0
Ratings Breakdown: 13 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $190.54 (-5.1% Upside)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits (ICs). It offers Fusion Design Platform, a digital design implementation solution; Verification Continuum Platform, which provides virtual prototyping, static and formal verification, simulation, emulation, field-programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Read More #3 - Repligen (
NASDAQ:RGEN)
Consensus Rating: Buy
Rating Score: 3.2
Ratings Breakdown: 6 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $136.67 (-12.1% Upside)
Repligen Corporation develops, manufactures, and sells products used to enhance the interconnected phases of the biological drug manufacturing process in North America, Europe, APAC, and internationally. It offers Protein A ligands to life sciences companies, which are the binding components of Protein A affinity resins; and growth factor products used to supplement cell culture media.
Read More #4 - Teleflex (
NYSE:TFX)
Consensus Rating: Buy
Rating Score: 3.0
Ratings Breakdown: 9 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $389.40 (4.3% Upside)
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous medications and other therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site; and devices for treating coronary and peripheral vascular disease.
Read More #5 - Prologis (
NYSE:PLD)
Consensus Rating: Buy
Rating Score: 2.9
Ratings Breakdown: 14 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $98.27 (-6.5% Upside)
Prologis, Inc is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2018, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 768 million square feet (71 million square meters) in 19 countries.
Read More #6 - Monolithic Power Systems (
NASDAQ:MPWR)
Consensus Rating: Buy
Rating Score: 3.0
Ratings Breakdown: 9 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $262.22 (-2.9% Upside)
Monolithic Power Systems, Inc designs, develops, and markets integrated power semiconductor solutions and power delivery architectures for consumer, computing and storage, industrial, automotive, and communications markets. It offers direct current (DC) to DC integrated circuits (ICs) that are used to convert and control voltages of various electronic systems, such as portable electronic devices, wireless LAN access points, computers, monitors, automobiles, and medical equipment.
Read More #7 - Zimmer Biomet (
NYSE:ZBH)
Consensus Rating: Buy
Rating Score: 3.0
Ratings Breakdown: 21 Buy Ratings, 3 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $146.50 (11.3% Upside)
Zimmer Biomet Holdings, Inc, together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through four segments: Spine, less Asia Pacific; Office Based Technologies; Craniomaxillofacial and Thoracic; and Dental.
Read More #8 - Service Co. International (
NYSE:SCI)
Consensus Rating: Buy
Rating Score: 3.0
Ratings Breakdown: 6 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $48.00 (8.2% Upside)
Service Corporation International provides deathcare products and services in the United States and Canada. The company operates through Funeral and Cemetery segments. Its funeral service and cemetery operations comprise funeral service locations, cemeteries, funeral service/cemetery combination locations, crematoria, and other businesses.
Read More #9 - 10x Genomics (
NYSE:TXG)
Consensus Rating: Buy
Rating Score: 3.0
Ratings Breakdown: 7 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $92.57 (-5.2% Upside)
10x Genomics, Inc, a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems. It offers chromium instruments, enzymes, reagents, microfluidic chips, and other consumable products, as well as software for analyzing biological systems.
Read More #10 - Encompass Health (
NYSE:EHC)
Consensus Rating: Buy
Rating Score: 2.9
Ratings Breakdown: 10 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $91.20 (34.1% Upside)
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
Read More #11 - Microsoft (
NASDAQ:MSFT)
Consensus Rating: Buy
Rating Score: 2.9
Ratings Breakdown: 32 Buy Ratings, 3 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $213.82 (0.3% Upside)
Microsoft Corporation develops, licenses, and supports software, services, devices, and solutions worldwide. Its company's Productivity and Business Processes segment offers Office 365 commercial products and services, such as Office, Exchange, SharePoint, Skype for Business, Microsoft Teams, and related Client Access Licenses (CALs); Office 365 consumer services, including Skype, Outlook.com, and OneDrive; LinkedIn online professional network; and Dynamics business solutions comprising financial management, enterprise resource planning, customer relationship management, supply chain management, and analytics applications for small and medium businesses, large organizations, and divisions of enterprises.
Read More #12 - salesforce.com (
NYSE:CRM)
Consensus Rating: Buy
Rating Score: 2.9
Ratings Breakdown: 40 Buy Ratings, 3 Hold Ratings, 1 Sell Ratings.
Consensus Price Target: $200.61 (-0.3% Upside)
salesforce.com, inc. develops enterprise cloud computing solutions with a focus on customer relationship management. The company offers Sales Cloud to store data, monitor leads and progress, forecast opportunities, and gain insights through analytics and relationship intelligence, as well as deliver quotes, contracts, and invoices.
Read More #13 - Uber Technologies (
NYSE:UBER)
Consensus Rating: Buy
Rating Score: 2.9
Ratings Breakdown: 34 Buy Ratings, 3 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $42.09 (28.8% Upside)
Uber Technologies, Inc develops and supports proprietary technology applications that enable independent providers of ridesharing, and meal preparation and delivery services to transact with end-users worldwide. The company operates in two segments, Core Platform and Other Bets. Its driver partners provide ridesharing services through a range of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, or taxis, as well as based on the number of riders under the UberBLACK, UberX, UberPOOL, Express POOL, and Uber Bus names; and restaurant and delivery partners provide meal preparation and delivery services under the Uber Eats name.
Read More #14 - Waste Connections (
NYSE:WCN)
Consensus Rating: Buy
Rating Score: 2.9
Ratings Breakdown: 12 Buy Ratings, 3 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $107.57 (6.3% Upside)
Waste Connections, Inc provides waste collection, transfer, disposal, and recycling services in the United States and Canada. The company operates through six segments: Southern, Western, Eastern, Canada, Central, and Exploration and Production (E&P). It offers collection services to residential, commercial, municipal, industrial, and E&P customers; landfill disposal services; and recycling services for various recyclable materials, including compost, cardboard, mixed paper, plastic containers, glass bottles, and ferrous and aluminum metals.
Read More #15 - Vertex Pharmaceuticals (
NASDAQ:VRTX)
Consensus Rating: Buy
Rating Score: 2.8
Ratings Breakdown: 21 Buy Ratings, 8 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $295.81 (6.1% Upside)
Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene.
Read More #16 - Copart (
NASDAQ:CPRT)
Consensus Rating: Buy
Rating Score: 2.6
Ratings Breakdown: 5 Buy Ratings, 4 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $86.13 (-10.5% Upside)
Copart, Inc provides online auctions and vehicle remarketing services. It offers a range of services for processing and selling vehicles over the Internet through its Virtual Bidding Third Generation Internet auction-style sales technology on behalf of vehicle sellers, insurance companies, banks and finance companies, charities, and fleet operators and dealers, as well as individual owners.
Read More #17 - Avalara (
NYSE:AVLR)
Consensus Rating: Buy
Rating Score: 3.0
Ratings Breakdown: 15 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $121.49 (-12.4% Upside)
Avalara, Inc provides cloud-based solutions for transaction tax compliance worldwide. It offers a suite of compliance solutions that enable businesses to address the complexity of transaction tax compliance; process transactions in real time; produce detailed records of transaction tax determinations; and reduce errors, audit exposure, and total transaction tax compliance costs.
Read More #18 - Amazon.com (
NASDAQ:AMZN)
Consensus Rating: Buy
Rating Score: 2.9
Ratings Breakdown: 45 Buy Ratings, 4 Hold Ratings, 1 Sell Ratings.
Consensus Price Target: $3,287.48 (4.2% Upside)
Amazon.com, Inc engages in the retail sale of consumer products and subscriptions in North America and internationally. The company operates through three segments: North America, International, and Amazon Web Services (AWS) segments. It sells merchandise and content purchased for resale from third-party sellers through physical stores and online stores.
Read More #19 - AutoZone (
NYSE:AZO)
Consensus Rating: Buy
Rating Score: 2.8
Ratings Breakdown: 14 Buy Ratings, 4 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $1,223.69 (2.2% Upside)
AutoZone, Inc retails and distributes automotive replacement parts and accessories. The company offers various products for cars, sport utility vehicles, vans, and light trucks, including new and remanufactured automotive hard parts, maintenance items, accessories, and non-automotive products. Its products include A/C compressors, batteries and accessories, bearings, belts and hoses, calipers, carburetors, chassis, clutches, CV axles, engines, fuel pumps, fuses, ignition and lighting products, mufflers, radiators, starters and alternators, thermostats, and water pumps.
Read More #20 - Wix.Com (
NASDAQ:WIX)
Consensus Rating: Buy
Rating Score: 2.9
Ratings Breakdown: 14 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $263.06 (-13.5% Upside)
Wix.com Ltd. develops and markets an Internet service that allows users to create Web content in Latin America, Europe, North America, Asia, and internationally. It offers Web development, design, and management solutions and apps through an online platform that enables its user base of businesses, organizations, professionals, and individuals to create a digital presence.
Read More
15 Technology Stocks that Analysts Love
There are more than 1,100 technology companies traded on public markets in the United States. Given the sheer number of hardware makers, social networks, software companies, service providers and other tech stocks, it can be hard to identify which tech companies are going to outperform the market.
Fortunately, Wall Street's brightest minds have already done this for us. Every year, analyst issue approximately 15,000 distinct recommendations for technology companies. Analysts don't always get their "buy" ratings right, but it's worth taking a hard look when several analysts from different brokerages and research firm are giving "strong buy" and "buy" ratings to the same tech stock.
This slide show lists the 15 technology companies that have the highest average analyst recommendations from Wall Street's equities research analysts over the last 12 months.
View the "15 Technology Stocks that Analysts Love" Here.
